Clinical Trial Update: Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of Fruquintinib with S-1 (tegafur/gimeracil/oteracil) in patients with metastatic colorectal cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• S-1 (tegafur/gimeracil/oteracil) (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Guangzhou University of Traditional Chinese Medicine | Conditions: Metastasis Colorectal Cancer, Colon Cancer | Phase 2 | Status: NOT_YET_RECRUITING